![Chris French](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris French
Chief Tech/Sci/R&D Officer at CHECKMATE PHARMACEUTICALS, INC.
Profile
Chris French is currently the Vice President-Scientific Affairs at Checkmate Pharmaceuticals, Inc. She holds a Master's in Business Administration from St. Thomas University (Florida) and an undergraduate degree from the University of Mankato.
Chris French active positions
Companies | Position | Start |
---|---|---|
CHECKMATE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/06/2016 |
Training of Chris French
University of Mankato | Undergraduate Degree |
St. Thomas University (Florida) | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Checkmate Pharmaceuticals, Inc.
![]() Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Chris French